GlassScriptPhysician profile
Julia Mae Langowski
NPI 1184711285
$1,893.79
in general payments reported to CMS, 2019-2025
18 companies · $553 in 2025
The $553 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $495 · 2024: $846 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,893.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $237.30 | 2023-2024 | Rexulti, Nuedexta |
| Neurocrine Biosciences, INC. | $173.76 | 2024-2025 | Ingrezza |
| Averitas Pharma INC. | $144.96 | 2025 | Qutenza |
| Abiomed | $139.15 | 2024 | Impella |
| Alexion Pharmaceuticals, INC. | $126.00 | 2025 | |
| Novo Nordisk INC | $124.74 | 2025 | Wegovy |
| Teva Pharmaceuticals USA, INC. | $124.74 | 2024 | Ajovy |
| Takeda Pharmaceuticals U.S.A., INC. | $123.75 | 2024 | Hyqvia |
| Lundbeck LLC | $115.00 | 2023 | Vyepti |
| Janssen Pharmaceuticals, INC | $97.38 | 2023 | Spravato |
| Amarin Pharma, INC. | $90.92 | 2024 | |
| Acadia Pharmaceuticals INC | $84.74 | 2024 | Nuplazid |
| Abbvie INC. | $82.21 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.51 | 2023 | |
| Boston Scientific Corporation | $53.34 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $39.78 | 2025 | |
| Dexcom, INC. | $35.07 | 2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $31.44 | 2023 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Langowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.